CN104817519A - 一类ca-4的衍生物、其制法及其医药用途 - Google Patents

一类ca-4的衍生物、其制法及其医药用途 Download PDF

Info

Publication number
CN104817519A
CN104817519A CN201510235806.3A CN201510235806A CN104817519A CN 104817519 A CN104817519 A CN 104817519A CN 201510235806 A CN201510235806 A CN 201510235806A CN 104817519 A CN104817519 A CN 104817519A
Authority
CN
China
Prior art keywords
arh
acid
ethyl acetate
compound
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510235806.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN104817519B (zh
Inventor
徐云根
刘坤
宋晓翰
陈泓竹
张宏波
张灵芝
朱启华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China Pharmaceutical University
Original Assignee
China Pharmaceutical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China Pharmaceutical University filed Critical China Pharmaceutical University
Priority to CN201510235806.3A priority Critical patent/CN104817519B/zh
Publication of CN104817519A publication Critical patent/CN104817519A/zh
Application granted granted Critical
Publication of CN104817519B publication Critical patent/CN104817519B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
CN201510235806.3A 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途 Active CN104817519B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510235806.3A CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510235806.3A CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Publications (2)

Publication Number Publication Date
CN104817519A true CN104817519A (zh) 2015-08-05
CN104817519B CN104817519B (zh) 2016-11-16

Family

ID=53728020

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510235806.3A Active CN104817519B (zh) 2015-05-11 2015-05-11 一类ca-4的衍生物、其制法及其医药用途

Country Status (1)

Country Link
CN (1) CN104817519B (it)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108990900A (zh) * 2018-08-15 2018-12-14 广州星燎生物科技有限公司 一种肺癌鸡胚绒毛尿囊膜m-cdx模型及制备方法
CN109006694A (zh) * 2018-08-15 2018-12-18 广州星燎生物科技有限公司 一种肝癌鸡胚绒毛尿囊膜m-cdx模型的建立方法

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138427A2 (en) * 2005-06-14 2006-12-28 Baylor University Combretastatin analogs with tubulin binding activity
WO2009118474A1 (fr) * 2008-02-28 2009-10-01 Sanofi-Aventis Procede de preparation de combretastatine
EP2338877A1 (en) * 2009-12-15 2011-06-29 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Combretastatin Derivatives and Uses Therefor
CN102219811A (zh) * 2011-04-14 2011-10-19 中国药科大学 Ca-4衍生物、其制法及其医药用途
CN102249987A (zh) * 2011-05-06 2011-11-23 兰州大学 一种考布他汀类化合物及其制备方法和用途
CN102863472A (zh) * 2012-10-15 2013-01-09 中国海洋大学 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用
CN102906076A (zh) * 2009-12-03 2013-01-30 赛诺菲 考布他汀衍生物制备方法
WO2013026942A1 (en) * 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents
CN102985410A (zh) * 2010-05-05 2013-03-20 拜罗伊特大学 在癌症的治疗中使用的考布他汀类似物
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途
WO2014181085A1 (en) * 2013-05-09 2014-11-13 Kenneth Dawson Bagshawe Tumour therapy

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138427A2 (en) * 2005-06-14 2006-12-28 Baylor University Combretastatin analogs with tubulin binding activity
WO2009118474A1 (fr) * 2008-02-28 2009-10-01 Sanofi-Aventis Procede de preparation de combretastatine
CN102906076A (zh) * 2009-12-03 2013-01-30 赛诺菲 考布他汀衍生物制备方法
EP2338877A1 (en) * 2009-12-15 2011-06-29 The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin Combretastatin Derivatives and Uses Therefor
CN102985410A (zh) * 2010-05-05 2013-03-20 拜罗伊特大学 在癌症的治疗中使用的考布他汀类似物
CN102219811A (zh) * 2011-04-14 2011-10-19 中国药科大学 Ca-4衍生物、其制法及其医药用途
CN102249987A (zh) * 2011-05-06 2011-11-23 兰州大学 一种考布他汀类化合物及其制备方法和用途
WO2013026942A1 (en) * 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Tubulin binding agents
CN102863472A (zh) * 2012-10-15 2013-01-09 中国海洋大学 考布他汀a-4类似物及其制备方法和在制备抗肿瘤药物中的应用
WO2014181085A1 (en) * 2013-05-09 2014-11-13 Kenneth Dawson Bagshawe Tumour therapy
CN103421057A (zh) * 2013-08-14 2013-12-04 合肥医工医药有限公司 康普瑞汀氨基糖缀合物、其制法及其医药用途
CN103524349A (zh) * 2013-10-19 2014-01-22 山东大学 Ca-4碳酸酯类衍生物、其制备方法、药物组合物与医药用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何书英,等: "考布他汀A-4衍生物CPU-XT-006对人脐静脉内皮细胞增殖、凋亡及VEGF、bFGF表达的影响", 《中国药科大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108990900A (zh) * 2018-08-15 2018-12-14 广州星燎生物科技有限公司 一种肺癌鸡胚绒毛尿囊膜m-cdx模型及制备方法
CN109006694A (zh) * 2018-08-15 2018-12-18 广州星燎生物科技有限公司 一种肝癌鸡胚绒毛尿囊膜m-cdx模型的建立方法

Also Published As

Publication number Publication date
CN104817519B (zh) 2016-11-16

Similar Documents

Publication Publication Date Title
ES2954451T3 (es) Composiciones y usos de derivados de amidina
CN109152933A (zh) 诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途
CN102424681B (zh) 酰基四氢-β-咔啉类化合物及其衍生物、用途及其制备方法
CN105392785B (zh) 1,3‑二取代的环戊烷衍生物
CN103086908A (zh) 一类n-苄基苯胺衍生物及其用途
CN107151250A (zh) 嘧啶类七元环化合物、其制备方法、药用组合物及其应用
BR112020014584A2 (pt) inibição do canal iônico do receptor de potencial transitório a1
CN107266461A (zh) 一种烷氧基二苯并吖庚因类化合物、其制备方法及医药用途
CN105705493A (zh) 喹唑啉衍生物、其制备方法、药物组合物和应用
CN108463222A (zh) 用于治疗疾病的杂环化合物
CN101417995B (zh) 苯氧基嘧啶衍生物及其制备方法和用途
CN104817519B (zh) 一类ca-4的衍生物、其制法及其医药用途
CN106573901A (zh) 富马酸酯类似物及其在治疗自身免疫性疾病或炎性疾病中的用途
CN106892920A (zh) 苦豆碱衍生物、其制备方法及用途
JP6104287B2 (ja) 四環系アントラキノン誘導体
CN104974108B (zh) 一类2,2’‑串联双噻唑类化合物及其制备方法和用途
CN107743488A (zh) 2‑氧代‑1,3,8‑三氮杂螺[4.5]癸烷‑3‑基]甲酸衍生物
CN101898985A (zh) Bcl-2蛋白的N-取代苯磺酰基-取代苯甲酰胺类小分子抑制剂及其应用
CN102753166B (zh) 四肽类似物及其制备和应用
CN111138449B (zh) 双靶向erk1和erk5抑制剂的制备及其抗肿瘤应用
CN104817553B (zh) 一种芳香基-杂环取代的嘧啶二胺类化合物及其衍生物及其医药用途
CN104045598B (zh) 一种含芳胺结构的硫脲类化合物及其制备方法和应用
CN104262277B (zh) 含硝基和卤苯取代的四氮唑乙酸类化合物、其制备方法及用途
CN107011312A (zh) 片叶苔素d含氮衍生物及其制备方法和在治疗肿瘤疾病中的用途
JP2022552019A (ja) 病的血管障害の治療のための作用物質としての3-フェニルスルホニル-キノリン誘導体

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant